Meeting
2021 ASCO Annual Meeting
A successful model of biosimilar adoption in a community oncology practice.
Authors
Lalan S. Wilfong
Texas Oncology/The US Oncology Network, Dallas, TX
Lalan S. Wilfong , Neal Dave , Jody S. Garey , Sara Toth , Jim R. Schwartz , Lance Ortega , Chris Sellers , Barry Don Brooks
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 6514)
DOI
10.1200/JCO.2021.39.15_suppl.6514
Abstract #
6514
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Quality Care Symposium
Scaled integration of FDA approved biosimilars: Closing the knowledge and adoption gaps.
First Author: David Michael Waterhouse
Poster
2021 ASCO Quality Care Symposium
Evaluation of real-world cost savings and utilization of biosimilar drugs in a community-based oncology practice.
First Author: Amit Sanyal
Poster
2013 ASCO Quality Care Symposium
Evaluating adherence to off-label policy at an academic outpatient cancer center and assessing reimbursement of high-cost drugs.
First Author: Gayle C. Blouin
Poster
2024 ASCO Annual Meeting
Medicare reimbursement trends of biological reference agents and their biosimilars.
First Author: John Albaugh